Literature DB >> 15481726

Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report.

Bruno Aouizerate1, Emmanuel Cuny, Corinne Martin-Guehl, Dominique Guehl, Helene Amieva, Abdelhamid Benazzouz, Colette Fabrigoule, Michele Allard, Alain Rougier, Bernard Bioulac, Jean Tignol, Pierre Burbaud.   

Abstract

Obsessive-compulsive disorder (OCD) is an anxiety disorder associated with recurrent intrusive thoughts and repetitive behaviors. Although conventional pharmacological and/or psychological treatments are well established and effective in treating OCD, symptoms remain unchanged in up to 30% of patients. Deep brain stimulation (DBS) of the anterior limb of the internal capsule has recently been proposed as a possible therapeutic alternative in treatment-resistant OCD. In the present study, the authors tested the hypothesis that DBS of the ventral caudate nucleus might be effective in a patient with intractable severe OCD and concomitant major depression. Psychiatric assessment included the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the Hamilton Depression Rating Scale (HDRS), the Hamilton Anxiety Rating Scale (HARS), and the Global Assessment of Functioning (GAF) Scale for determining the symptom severity of OCD, depression, and anxiety as well as the quality of pychosocial and occupational functioning, respectively. Neuropsychological assessment consisted of a wide range of tests primarily exploring memory and executive functions. Deep brain stimulation of the ventral caudate nucleus markedly improved symptoms of depression and anxiety until their remission, which was achieved at 6 months after the start of stimulation (HDRS < or = 7 and HARS < or = 10). Remission of OCD (Y-BOCS < 16) was also delayed after 12 or 15 months of DBS. The level of functioning pursuant to the GAF scale progressively increased during the 15-month follow-up period. No neuropsychological deterioration was observed, indicating that DBS of the ventral caudate nucleus could be a promising strategy in the treatment of refractory cases of both OCD and major depression.

Entities:  

Mesh:

Year:  2004        PMID: 15481726     DOI: 10.3171/jns.2004.101.4.0682

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  72 in total

Review 1.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

2.  [Brain stimulation procedures. Transcranial magnetic stimulation, magnetic seizure therapy and deep brain stimulation].

Authors:  T E Schläpfer; S Kayser
Journal:  Nervenarzt       Date:  2012-01       Impact factor: 1.214

Review 3.  Deep brain stimulation for psychiatric disorders.

Authors:  Paul Sloan Larson
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

4.  Transcranial direct current stimulation for major depression: a general system for quantifying transcranial electrotherapy dosage.

Authors:  Marom Bikson; Peter Bulow; John W Stiller; Abhishek Datta; Fortunato Battaglia; Sergei V Karnup; Teodor T Postolache
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

Review 5.  Tracking the mechanisms of deep brain stimulation for neuropsychiatric disorders.

Authors:  J Luis Lujan; Ashutosh Chaturvedi; Cameron C McIntyre
Journal:  Front Biosci       Date:  2008-05-01

6.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

Review 7.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Kyle A B Lapidus; Emily R Stern; Heather A Berlin; Wayne K Goodman
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

8.  Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review.

Authors:  Shaheen E Lakhan; Enoch Callaway
Journal:  BMC Res Notes       Date:  2010-03-04

9.  Depressive-like behavior in mice recently recovered from motor disorders after 3-nitropropionic acid intoxication.

Authors:  Xiao-Min Li; Bing-Gen Zhu; Sha Ma; Wei Zhou; Zheng Wei; Yu-Xiang Zheng; Xu-Dong Zhao; Rong-Shen Zhu
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

Review 10.  Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review.

Authors:  Pablo Andrade; Lieke H M Noblesse; Yasin Temel; Linda Ackermans; Lee W Lim; Harry W M Steinbusch; Veerle Visser-Vandewalle
Journal:  Acta Neurochir (Wien)       Date:  2010-01-26       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.